Boxer Capital, LLC
Total reported value
—
Reporting period: 2024-12-31 · Number of holdings: 1
Boxer Capital, LLC disclosed 1 holdings in its latest 13F filing for the period ending 2024-12-31, with total reported value of — and a quarterly turnover rate of 0.0%.
Personality snowflake
- Concentration
- 0
- Portfolio Stability
- 0
- Momentum/Contrarian
- 50
- Sector conviction
- 0
- Diversification
- 2
- Sizing Uniformity
- —
Recent moves
Sold out RVMD
Sold out TYRA
Sold out NUVL
Sold out ONC
Sold out CYTK
Sold out SWTXUSD
Holdings Map
Top 10 holdings by weight
Full holdings list this quarter
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Ikena Oncology INC | Stock-Other | — | — | — |
Reported value over time
Sector allocation
Not enough sector-mapped data yet
Sector allocation over time
Quarterly history
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2024-12-31 | 1 | — | 0 | |
| 2024-09-30 | 68 | $2.0B | 0 | |
| 2024-06-30 | 61 | $1.9B | 0 | |
| 2024-03-31 | 59 | $2.0B | 0 | |
| 2023-12-31 | 52 | $2.0B | 0 | |
| 2023-09-30 | 73 | $1.9B | 0 | |
| 2023-06-30 | 79 | $2.2B | 0 | |
| 2023-03-31 | 75 | $2.0B | 0 | |
| 2022-12-31 | 71 | $1.9B | 0 | |
| 2022-09-30 | 73 | $1.8B | 0 | |
| 2022-06-30 | 76 | $1.6B | 0 | |
| 2022-03-31 | 74 | $1.9B | 0 | |
| 2021-12-31 | 71 | $2.6B | 0 | |
| 2021-09-30 | 88 | $2.9B | 0 | |
| 2021-06-30 | 95 | $2.8B | 24 | |
| 2021-03-31 | 85 | $2.9B | 36 | |
| 2020-12-31 | 78 | $3.1B | 56 | |
| 2020-09-30 | 75 | $2.9B | 56 | |
| 2020-06-30 | 65 | $2.3B | 54 | |
| 2020-03-31 | 62 | $1.5B | 67 | |
| 2019-12-31 | 51 | $1.8B | 73 | |
| 2019-09-30 | 49 | $1.4B | 100 | |
| 2019-06-30 | 35 | $1.1B | 0 | |
| 2019-03-31 | 23 | $864.7M | 69 | |
| 2018-12-31 | 24 | $809.4M | 50 | |
| 2018-09-30 | 24 | $901.2M | 43 | |
| 2018-06-30 | 26 | $883.1M | 67 | |
| 2018-03-31 | 33 | $936.9M | 63 | |
| 2017-12-31 | 26 | $547.1M | 63 | |
| 2017-09-30 | 30 | $439.3M | 49 | |
| 2017-06-30 | 27 | $420.5M | 45 | |
| 2017-03-31 | 31 | $457.6M | 60 | |
| 2016-12-31 | 28 | $258.5M | 52 | |
| 2016-09-30 | 28 | $223.1M | 86 | |
| 2016-06-30 | 23 | $112.8M | 65 | |
| 2016-03-31 | 22 | $102.2M | 100 | |
| 2015-12-31 | 15 | $115.8M | 0 |
Holding changes this quarter
Boxer Capital, LLC's most significant position changes for 2024-12-31: Sold out: Revolution Medicines INC (RVMD); Sold out: Tyra Biosciences INC (TYRA); Sold out: Nuvalent Inc-a (NUVL); Sold out: Beone Medicines Ltd-adr (ONC); Sold out: Cytokinetics INC (CYTK).
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | RVMD | Revolution Medicines INC | — | EXIT | Sold out |
| 2 | TYRA | Tyra Biosciences INC | — | EXIT | Sold out |
| 3 | NUVL | Nuvalent Inc-a | — | EXIT | Sold out |
| 4 | ONC | Beone Medicines Ltd-adr | — | EXIT | Sold out |
| 5 | CYTK | Cytokinetics INC | — | EXIT | Sold out |
| 6 | SWTXUSD | Springworks Therapeutics INC | — | EXIT | Sold out |
| 7 | ✓ | Merus N V | — | EXIT | Sold out |
| 8 | SRPT | Sarepta Therapeutics INC | — | EXIT | Sold out |
| 9 | RNAGBP | Avidity Biosciences INC | — | EXIT | Sold out |
| 10 | IDYA | Ideaya Biosciences INC | — | EXIT | Sold out |
| 11 | TNGX | Tango Therapeutics INC | — | EXIT | Sold out |
| 12 | ARGX | Argenx Se - Adr | — | EXIT | Sold out |
| 13 | APLSUSD | Apellis Pharmaceuticals INC | — | EXIT | Sold out |
| 14 | AKRO | Akero Therapeutics INC | — | EXIT | Sold out |
| 15 | ANAB | Anaptysbio INC | — | EXIT | Sold out |
| 16 | AXSM | Axsome Therapeutics INC | — | EXIT | Sold out |
| 17 | 2662247D | Iteos Therapeutics INC | — | EXIT | Sold out |
| 18 | LEGN | Legend Biotech Corp-adr | — | EXIT | Sold out |
| 19 | GERN | Geron CORP | — | EXIT | Sold out |
| 20 | ✓ | Third Harmonic Bio INC | — | EXIT | Sold out |
| 21 | RCKT | Rocket Pharmaceuticals INC | — | EXIT | Sold out |
| 22 | RCUS | Arcus Biosciences INC | — | EXIT | Sold out |
| 23 | TIL | Instil Bio INC | — | EXIT | Sold out |
| 24 | XENE | Xenon Pharmaceuticals INC | — | EXIT | Sold out |
| 25 | IMVT | Immunovant INC | — | EXIT | Sold out |
| 26 | KYMR | Kymera Therapeutics INC | — | EXIT | Sold out |
| 27 | SYRE | Spyre Therapeutics INC | — | EXIT | Sold out |
| 28 | KURA | Kura Oncology INC | — | EXIT | Sold out |
| 29 | 4XC1 | Kalvista Pharmaceuticals INC | — | EXIT | Sold out |
| 30 | NKTX | Nkarta INC | — | EXIT | Sold out |
| 31 | ORIC | Oric Pharmaceuticals INC | — | EXIT | Sold out |
| 32 | GPCR | Structure Therapeutics INC | — | EXIT | Sold out |
| 33 | FATE | Fate Therapeutics INC | — | EXIT | Sold out |
| 34 | ELVN | Enliven Therapeutics INC | — | EXIT | Sold out |
| 35 | REPL | Replimune Group INC | — | EXIT | Sold out |
| 36 | DAWNGBX | Day One Biopharmaceuticals I | — | EXIT | Sold out |
| 37 | CGEM | Cullinan Therapeutics INC | — | EXIT | Sold out |
| 38 | ARVN | Arvinas INC | — | EXIT | Sold out |
| 39 | CLYM | Climb Bio INC | — | EXIT | Sold out |
| 40 | RLAY | Relay Therapeutics INC | — | EXIT | Sold out |
| 41 | NRIX | Nurix Therapeutics INC | — | EXIT | Sold out |
| 42 | PRTA | Prothena Corporation plc | — | EXIT | Sold out |
| 43 | QURE | uniQure N.V. | — | EXIT | Sold out |
| 44 | APGE | Apogee Therapeutics INC | — | EXIT | Sold out |
| 45 | OLMA | Olema Pharmaceuticals INC | — | EXIT | Sold out |
| 46 | IOVA | Iovance Biotherapeutics INC | — | EXIT | Sold out |
| 47 | IPSC | Century Therapeutics INC | — | EXIT | Sold out |
| 48 | JSPR | Jasper Therapeutics INC | — | EXIT | Sold out |
| 49 | SANA | Sana Biotechnology INC | — | EXIT | Sold out |
| 50 | 430 | Terns Pharmaceuticals INC | — | EXIT | Sold out |
FAQ
What is Boxer Capital, LLC and what type of investor is it?
What are Boxer Capital, LLC's largest equity positions?
What changes did Boxer Capital, LLC make in its most recent portfolio filing?
What sectors does Boxer Capital, LLC focus on?
Peer Institutions
Institutions with a similar AUM
Cowen And Company, LLC
Total reported value
—
1 stks
2024-12-31
Kresge Foundation
Total reported value
—
1 stks
2019-12-31
Resource America, INC.
Total reported value
—
1 stks
2021-09-30